Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Enrolling by invitation1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

enrolling_by_invitation133%
not_yet_recruiting133%
recruiting133%

Recent Activity

1 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Contrast-enhanced Mammography in Women With a Personal History of Breast Cancer and Dense Breast Tissue: Benefit?

NCT06993246
enrolling_by_invitation

Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome

NCT06843096
recruitingnot_applicable

Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial

NCT06636370

Clinical Trials (3)

Showing 3 of 3 trials
NCT06993246Not Applicable

Contrast-enhanced Mammography in Women With a Personal History of Breast Cancer and Dense Breast Tissue: Benefit?

Not Yet Recruiting
NCT06843096

Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome

Enrolling By Invitation
NCT06636370Not Applicable

Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 Trial

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3